112 results on '"Spergel, Jonathan M"'
Search Results
2. Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
3. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis
4. Persistent esophageal changes after histologic remission in eosinophilic esophagitis
5. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial
6. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
7. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
8. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
9. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
10. The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders
11. Might biologics serve to interrupt the atopic march?
12. Nasopharyngeal airway dual-transcriptome of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study
13. Esophageal remodeling in eosinophilic esophagitis: Relationships to luminal captured biomarkers of inflammation and periostin
14. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions
15. Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field
16. Anaphylaxis knowledge gaps and future research priorities: A consensus report
17. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
18. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.
19. Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites.
20. Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors
21. Multiethnic genome-wide and HLA association study of total serum IgE level
22. Severity grading system for acute allergic reactions: A multidisciplinary Delphi study
23. Persistent, refractory, and biphasic anaphylaxis: A multidisciplinary Delphi study
24. Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort
25. Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet?
26. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
27. Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α
28. Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”
29. The atopic march and atopic multimorbidity: Many trajectories, many pathways
30. Advances in atopic dermatitis in 2017
31. Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites
32. International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
33. Reply
34. Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin–basophil axis
35. Basophils and allergic inflammation
36. Food protein–induced enterocolitis syndrome: Not so rare after all!
37. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology–European Academy of Allergy and Clinical Immunology PRACTALL consensus report
38. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet
39. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial
40. Pediatric and adult EoE: A spectrum or distinct diseases?
41. Eosinophilic esophagitis: Updated consensus recommendations for children and adults
42. Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin
43. Double-blind food challenges can be conducted effectively by using interspersed active and placebo doses among children
44. Natural history of cowʼs milk allergy
45. Working with the US Food and Drug Administration: Progress and timelines in understanding and treating patients with eosinophilic esophagitis
46. Administration of influenza vaccine to pediatric patients with egg-induced anaphylaxis
47. Resolution of acute IgE-mediated allergy with development of eosinophilic esophagitis triggered by the same food
48. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis
49. Effect of topical pimecrolimus on epicutaneous skin testing
50. Atopic dermatitis and the atopic march
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.